PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
122 episodes - English - Latest episode: 9 days ago - ★★★★ - 10 ratingsPeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Joseph I. Sirven, MD - Generalized Tonic-Clonic Seizures: Clinical Pearls for Recognition and Optimal Management
October 11, 2019 23:00 - 25 minutesGo online to PeerView.com/PDN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in neurology discusses the diagnosis and management of patients with generalized tonic-clonic seizures. Upon completion of this activity, participants should be better able to: Differentiate generalized tonic-clonic seizures from other seizure types in patients with epilepsy, Recognize the significance of early antiepileptic drug tre...
Michael Polydefkis, MD - Clinical Pearls for the Accurate Diagnosis and Optimal Treatment of Hereditary ATTR Amyloidosis
July 31, 2019 23:00 - 21 minutesGo online to PeerView.com/HMV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this infographic-based activity, an expert neurologist shares clinical pearls for accurately diagnosing and optimally treating patients with hereditary ATTR amyloidosis. Upon completion of this activity, participants should be better able to: Describe the common symptoms and underlying genetic mechanisms of hereditary ATTR amyloidosis, Apply genetic ...
Bruce Cree, MD, PhD, MAS - Examining Late-Breaking Data on Disease-Modifying Therapies for the Treatment of Multiple Sclerosis — An Update From Philadelphia
July 29, 2019 23:00 - 33 minutesGo online to PeerView.com/ECH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in the treatment of multiple sclerosis reviews updates from the 2019 annual meeting of the American Academy of Neurology in Philadelphia, including new data on approved oral disease-modifying therapies, approved monoclonal antibodies, and selected emerging therapies. Upon completion of this activity, participants should be be...
Edward J. Fox, MD, PhD - Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers
July 17, 2019 23:00 - 49 minutesGo online to PeerView.com/EHV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Several disease-modifying therapies (DMTs) are now approved for MS management, and a number of emerging therapies are under investigation for the treatment of this disease. In this unique PeerView Talks activity, based on a live symposium held at the 2019 CMSC Annual Meeting, leading experts engage in a live discussion of current data on available and i...
Adam Boxer, MD - Progressive Supranuclear Palsy: Examining Diagnostic Considerations and Emerging Treatment Approaches
July 08, 2019 23:00 - 27 minutesGo online to PeerView.com/YPK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a neurologist discusses the symptoms, diagnosis, and management of patients with progressive supranuclear palsy, focusing on pathophysiology, detection, and therapeutic approaches currently under investigation. Upon completion of this activity, participants should be better able to: Identify patients with progressive supranuclear palsy...
Jerry Vockley, MD, PhD - Diminishing the Burden of Phenylketonuria During Adulthood: New Science & Encouraging Stories Highlighting the Critical Role of Adjunctive Therapy in Alleviating Neurocognitive Symptoms and Easing Dietary Constraints
June 14, 2019 23:00 - 54 minutesGo online to PeerView.com/UGR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.In this activity, experts in PKU discuss available adjunctive treatments, which provide an opportunity to lower blood Phe levels while potentially easing dietary restrictions and lessening the burden of this disease. Upon completion of this activity, participants should be better able to: Employ current practice guidelines and standards of care when mana...
Kevin N. Sheth, MD - Exploring Unmet Needs in Large Hemispheric Infarction: Clinical Insights on Early Recognition and Emerging Therapy
June 02, 2019 23:00 - 29 minutesGo online to PeerView.com/AKZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in neurology discusses current and emerging interventions to reduce morbidity and mortality due to cerebral edema in patients with LHI. Upon completion of this activity, participants should be better able to: Apply evidence-based strategies for evaluation and management of large hemispheric infarction (LHI), Recognize the lat...
Stewart J. Tepper, MD, FAHS - Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention
April 26, 2019 23:00 - 53 minutesGo online to PeerView.com/DCR860 to view the entire program with slides. Migraine, a common neurovascular brain disorder, represents a severe and widespread health problem. In recent years a number of novel therapies for the acute treatment and prevention of migraine have been developed. These include centrally acting serotonin (5HT1F) agonists and therapies directed against the calcitonin gene-related peptide (CGRP) ligand and its receptor. In this activity, based on a recent live s...
Anup D. Patel, MD, FAAN - Harnessing the Full Potential of Available Therapies for the Treatment of Lennox-Gastaut Syndrome: A Story Behind the Science
April 08, 2019 23:00 - 26 minutesGo online to PeerView.com/XYB860 to view the entire program with slides. In this activity, an expert in the management of Lennox-Gastaut syndrome discusses the challenges of identifying, diagnosing, and treating patients with this condition. Upon completion of this activity, participants should be better able to: Identify patients with Lennox-Gastaut syndrome based on the presence of cardinal symptoms and hallmark features, Cite current data on approved pharmacologic therapies for th...
Aaron Boster, MD - Improving Outcomes in Multiple Sclerosis Through the Practice of Shared Decision-Making in Disease-Modifying Therapy Selection
March 13, 2019 23:00 - 22 minutesGo online to PeerView.com/PPP860 to view the entire program with slides. In this activity, an expert in multiple sclerosis discusses available disease-modifying therapies and strategies for shared decision-making for patients with multiple sclerosis. Upon completion of this activity, participants should be better able to: Recognize the mechanisms of action of disease-modifying therapeutic options for patients with multiple sclerosis, Apply available data on disease-modifying therapie...
Marwan Sabbagh, MD, FAAN - Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?
February 19, 2019 23:00 - 45 minutesTaking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?
Barry Singer, MD - Taking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
January 23, 2019 23:00 - 43 minutesTaking Stock of Late-Breaking Data on Disease-Modifying Therapies for Multiple Sclerosis: What Are the Key Learnings From Berlin?
Richard S. Finkel, MD - Breaking Down the Barriers to Optimal Spinal Muscular Atrophy Care: Overcoming Diagnostic Delays, Facilitating Early Treatment, and Easing Caregiver Burden
January 18, 2019 23:00 - 54 minutesBreaking Down the Barriers to Optimal Spinal Muscular Atrophy Care: Overcoming Diagnostic Delays, Facilitating Early Treatment, and Easing Caregiver Burden
Mark S. Sulkowski, MD - Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education
January 14, 2019 23:00 - 1 hourAddressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education
Steven Brem, MD - Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era
January 09, 2019 23:00 - 54 minutesTransforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era
Joseph McEvoy, MD - Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options
January 04, 2019 23:00 - 46 minutesImproving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options
Stewart J. Tepper, MD, FAHS - Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
December 10, 2018 23:00 - 1 hourExploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
Stewart J. Tepper, MD, FAHS - Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
December 10, 2018 23:00 - 1 hourExploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?
Deborah I. Friedman, MD, MPH - Improving the Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention: How Is the Role of the Primary Care Clinician Evolving?
December 05, 2018 23:00 - 35 minutesImproving the Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention: How Is the Role of the Primary Care Clinician Evolving?
Loren del Mar Pena, MD, PhD - Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
November 19, 2018 23:00 - 24 minutesExpert Insights on Available and Emerging Therapies for the Management of Pompe Disease
Hiroshi Mitsumoto, MD, DSc - Assessing the Role of Recent Therapeutic Breakthroughs in the Treatment of Amyotrophic Lateral Sclerosis
October 19, 2018 23:00 - 21 minutesAssessing the Role of Recent Therapeutic Breakthroughs in the Treatment of Amyotrophic Lateral Sclerosis
J. Sloan Manning, MD - Overcoming Disparities in the Accurate Diagnosis and Optimal Management of MDD in Rural America
August 27, 2018 23:00 - 38 minutesOvercoming Disparities in the Accurate Diagnosis and Optimal Management of MDD in Rural America